Texas Heart Institute Home
Continuing Medical Education
THI Home
for Program Director & Speaker
Resources for Physicians
For Commercial Supporters
Contact Us
View Site Map

To participate in this event:
1. Read CME information.
2. View course materials.
3. Complete assessment. 
4. Obtain CME credit.

Heart Failure Symposium 2009

Heart Failure: Surgical and Medical Breakthrough
in Current Practice

Date of Online Release: May 26, 2009
Recent Review: June 2014
Termination Date: July 10, 2015
Credits: 2.25 AMA PRA Category 1 Credits™

To view presentations, see Course Materials below.

CME Information - Overview

Despite advances in understanding the myriad of processes leading to heart failure and novel modalities in treating it, heart failure remains a fatal condition. In the past few years, several major advances in treating advanced heart failure have occurred, including surgical and percutaneous interventions. 

Educational Objectives
The intended result of this activity is increased knowledge. At the conclusion of this symposium, participants should be able to--

  • Identify the interventional options in treating heart failure.
  • Discuss the indications for surgical treatment of heart failure.
  • Describe the emerging modalities in treating heart failure to include cell therapy and devices.

Target Audience
The intended audience for this continuing medical education activity includes cardiologists, heart failure specialists, interventional and electrophysiology cardiologists, and cardiovascular surgeons.

Method of Instruction / Participation
This online enduring material comprises slide sets with text and audio derived from a live symposium with post activity assessment and evaluation.

Evaluation / Feedback
We value your comments; please send your suggestions and comments to the Office of Continuing Medical Education at Texas Heart Institute, cme@heart.thi.tmc.edu.

Program Director

Reynolds M. Delgado III, MD, FACC

Reynolds M. Delgado III, MD
Texas Heart Institute
Houston, Texas

Acknowledgement of Support

We acknowledge the following for their support of the live event from which this activity was derived: ARCA biopharma, Inc., Boston Scientific Corporation, CardiacAssist, Inc., CircuLite, Inc., Levitronix, St. Jude Medical, Inc., Sunshine Heart, Inc., and Thoratec Corporation. No grants were received for the production of these online enduring materials

Accreditation / Credit Designation

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Texas Heart Institute designates this educational activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Estimated Study Time
The estimated time to complete this activity, including review of the materials and completion of the course assessment is 2 hours and 25 minutes.

Repurposing Statement
If you previously completed and received credit for the live CME-sponsored symposium entitled, Heart Failure: Surgical and Medical Breakthrough in Current Practice on March 28, 2009, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.

Disclosure of Relationships
It is the intent of the Texas Heart Institute to ensure that its educational mission and its continuing medical activities in particular, should not be influenced by the special interests of individuals associated with its program.

Faculty Disclosure
In accordance with the guidelines of the Accreditation Council for Continuing Medical Education, faculty members have disclosed their relationships, either with one or more of the manufacturers of commercial products discussed, or with one or more of the corporate organizations offering educational grants for the live continuing medical education activity.

J. Timothy Baldwin, PhD does not have any disclosures relevant to this program.

Reynolds M. Delgado III, MD (Program Director) discloses the following, relevant to this program: Consultant/Honoraria: Boston Scientific Corporation; Speaker's Bureau: GlaxoSmithKline.

O. H. Frazier, MD does not have any disclosures relevant to this program.

Douglas L. Mann, MD discloses the following, relevant to this program: Grant/Research Support: National Institutes of Health; Consultant: Acorn Cardiovascular, Inc. and Medtronic, Inc.; Scientific Advisory Board: ARMGO Pharma, Inc., Lpath Inc., Nile Pharmaceuticals, and Cardiokine, Inc.

James T. Willerson, MD does not have any disclosures relevant to this program.

James B. Young, MD does not have any disclosures relevant to this program.

Course Materials and CME Credit

This enduring material comprises 8 presentations. By clicking on the course materials link below, you acknowledge that you have reviewed the CME information provided above. After viewing all presentations, you must complete an assessment and evaluation to obtain CME credit for this activity.

Course Materials- Heart Failure Symposium

Return to Explore Archived Symposia.
Find Us on Facebook!

Please contact our Webmaster with questions or comments.
Terms of Use and Privacy Policy
© Copyright Texas Heart Institute. All rights reserved.
Texas Heart Institute, Texas Heart, Texas Heart Institute Journal, THI, Heart Owner's, Leading With the Heart and Heart of Discovery are members of the
family of trademarks of the Texas Heart Institute.